Aclaris Therapeutics
ACRS
ACRS
100 hedge funds and large institutions have $579M invested in Aclaris Therapeutics in 2016 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 40 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
72% more funds holding
Funds holding: 58 → 100 (+42)
46% more capital invested
Capital invested by funds: $396M → $579M (+$183M)
Holders
100
Holding in Top 10
8
Calls
–
Puts
–
Top Buyers
| 1 | +$22.5M | |
| 2 | +$19.5M | |
| 3 | +$16.9M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$12.2M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$12.2M |
Top Sellers
| 1 | -$59.5M | |
| 2 | -$39.6M | |
| 3 | -$24.6M | |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$5.16M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$1.49M |